Literature DB >> 16435213

Rhabdomyolysis in early-onset very long-chain acyl-CoA dehydrogenase deficiency despite normal glucose after fasting.

H M Engbers1, L Dorland, M G M de Sain, P F Eskes, G Visser.   

Abstract

A patient with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency presented in the neonatal period with hypoketotic hypoglycaemia and at the age of 1 year with rhabdomyolysis and normal glucose after fasting. Rhabdomyolysis may occur in the absence of hypoglycaemia in young infants as well as in older patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435213     DOI: 10.1007/s10545-005-0190-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  2 in total

1.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.

Authors:  C Vianey-Saban; P Divry; M Brivet; M Nada; M T Zabot; M Mathieu; C Roe
Journal:  Clin Chim Acta       Date:  1998-01-12       Impact factor: 3.786

2.  Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.

Authors:  Charles R Roe; Lawrence Sweetman; Diane S Roe; France David; Henri Brunengraber
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

  2 in total
  8 in total

1.  Anesthetic management for a patient with very-long-chain acyl-coenzyme A dehydrogenase deficiency.

Authors:  Kenji Iwata; Kumiko Tanabe; Yoko Sugiyama; Midori Tanaka; Motoyasu Takenaka; Hiroki Iida
Journal:  J Anesth       Date:  2012-07-31       Impact factor: 2.078

2.  Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.

Authors:  Margarita Tenopoulou; Jie Chen; Jean Bastin; Michael J Bennett; Harry Ischiropoulos; Paschalis-Thomas Doulias
Journal:  J Biol Chem       Date:  2015-03-03       Impact factor: 5.157

3.  Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy.

Authors:  S Gobin-Limballe; F Djouadi; F Aubey; S Olpin; B S Andresen; S Yamaguchi; H Mandel; T Fukao; J P N Ruiter; R J A Wanders; R McAndrew; J J Kim; J Bastin
Journal:  Am J Hum Genet       Date:  2007-10-29       Impact factor: 11.025

Review 4.  Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids.

Authors:  Alexandre Umpierrez Amaral; Moacir Wajner
Journal:  Front Genet       Date:  2020-11-27       Impact factor: 4.599

5.  Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD).

Authors:  Abbe N Vallejo; Henry J Mroczkowski; Joshua J Michel; Michael Woolford; Harry C Blair; Patricia Griffin; Elizabeth McCracken; Stephanie J Mihalik; Miguel Reyes-Mugica; Jerry Vockley
Journal:  Clin Transl Immunology       Date:  2021-06-27

Review 6.  Hypoglycaemia related to inherited metabolic diseases in adults.

Authors:  Claire Douillard; Karine Mention; Dries Dobbelaere; Jean-Louis Wemeau; Jean-Marie Saudubray; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2012-05-15       Impact factor: 4.123

7.  Rhabdomyolysis in a neonate due to very long chain acyl CoA dehydrogenase deficiency.

Authors:  Jessica Scott Schwoerer; Gena Cooper; Sandra van Calcar
Journal:  Mol Genet Metab Rep       Date:  2015-03-30

Review 8.  Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.

Authors:  Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  Biosci Rep       Date:  2015-11-20       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.